Skip to main content
SpringerLink
Log in

Intrazerebrale Blutung unter der Therapie mit Thrombozytenfunktionshemmern

Kein erhöhtes Hirnblutungsrisiko bei Wiederbeginn der Plättchenhemmung

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  • RESTART Collaborators. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet 2019, 393; 2613–23

    Article  Google Scholar 

  • Salman RAS, Minks DP, Mitra D et al. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial. Lancet Neurol 2019; 18: 643–52

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Fakultät der Universität Duisburg-Essen, Essen, Deutschland

    Hans-Christoph Diener

Authors
  1. Hans-Christoph Diener
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Christoph Diener.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diener, HC. Kein erhöhtes Hirnblutungsrisiko bei Wiederbeginn der Plättchenhemmung. InFo Neurologie 21, 23–24 (2019). https://doi.org/10.1007/s15005-019-0128-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-019-0128-9

Search

Navigation